1. Peer Review Process

All submissions to The Indonesian Journal of Kidney and Hypertension will undergo a stringent screening and evaluation process to ascertain their alignment with the journal's scope and their academic quality and novelty within the field. The journal utilizes a double-blind peer review system, ensuring anonymity between authors and reviewers. The process will proceed as follows:

  • Initial evaluation: Upon submission, a newly received manuscript will undergo evaluation by the Assistant Editor to ensure adherence to basic submission criteria, and by one of the Editor-in-Chiefs to assess its alignment with the scope of The Indonesian Journal of Kidney and Hypertension. Manuscripts failing to meet these initial criteria will be rejected without further review.
  • Peer review: Following successful completion of the initial screening, the manuscript will be assigned to a handling editor, who will subsequently distribute it to a minimum of two experts within the pertinent field for a double-blind peer review process.
  • First decision: A decision regarding a peer-reviewed manuscript will be rendered only after receiving at least two review reports. At this juncture, the manuscript may either be rejected, requested for revisions (major or minor), or accepted. If accepted, the manuscript will be returned to the submitting author for formatting. The ultimate decision to accept the manuscript will be made by the Editor-in-Chief, following the recommendation of the handling editor.
  • Revision phase: A manuscript necessitating revisions will be returned to the submitting author, who will have a period of up to three weeks to format and revise the manuscript. Subsequently, the revised manuscript will undergo review by the handling editor. The handling editor will assess the adequacy and appropriateness of the changes, as well as the author(s)'s responsiveness to the reviewers' comments and suggestions. If the revisions are deemed insufficient, the cycle will be reiterated, with the manuscript returned to the submitting author for further revision.

2. Plagiarism and Data Fabrication

Plagiarism, in any manifestation, is considered unethical publishing conduct and is not tolerated. We define plagiarism as the replication of text, concepts, images, or data from another origin, including one's own publications, without acknowledging the original sources. To ascertain originality, all submitted manuscripts undergo screening via plagiarism detection software, specifically Turnitin. Manuscripts revealing a similarity index exceeding 19% may face rejection.

Data integrity is paramount in scientific research, thus it is imperative that presented data are original and not subject to inappropriate practices such as selective exclusion, manipulation, enhancement, or fabrication. This encompasses actions such as excluding data points to artificially boost significance, fabricating data, cherry-picking results to support a specific conclusion while ignoring contradictory data, and selectively choosing analysis tools or methods (including p-hacking) to favor a desired outcome. To ensure transparency and rigor, it is strongly recommended that methods and analyses be preregistered.

3. Open Access Information and Policy

All articles disseminated in The Indonesian Journal of Kidney and Hypertension undergo rigorous peer review and are promptly accessible worldwide under an open access license, without any embargo period. Consequently, unrestricted and complimentary access to the full-text of all published articles is extended to all individuals. Reproduction of published materials, whether modified or unmodified, for non-commercial purposes is permitted, provided proper citation of the original publication is included.

4. Article Processing Charges

The Indonesian Journal of Kidney and Hypertension operates as a fully open-access publication without any associated costs. There are no subscription fees for readers or charges for authors regarding page or figure inclusion. Expenses related to peer review administration, technical editing, typesetting, professional article production, website maintenance, and assigning a unique Digital Object Identifier (DOI) for each article, alongside other publishing tasks, are borne by the journal and do not require payment from authors. As a result, no article processing charges (APC) are levied for submission [No Submission Fee] of accepted articles. Additionally, certain items such as Corrections, Erratum, and Retractions are published without charge. The Perhimpunan Nefrologi Indonesia/Indonesian Society of Nephrology (Pernefri/InaSN) covers the expenses associated with facilitating open access to the articles.

5. Authorship and Changes to Authorship

All authors are expected to have significantly contributed to each of the following aspects:

  • The conceptualization and design of the study, acquisition of data, or analysis and interpretation of data.
  • Drafting the manuscript or critically revising it for significant intellectual content.
  • Giving final approval of the version to be submitted. Authors are required to meticulously review the list and order of authors before submitting their manuscript, ensuring accuracy and completeness.

Any modifications to the authorship list, such as additions, deletions, or rearrangements, should only be made before the manuscript's acceptance and with the approval of the journal Editor. To initiate such changes, the corresponding author must provide the Editor with: (1) a rationale for the alterations in the author list and (2) written confirmation (via email or letter) from all authors, indicating their agreement with the proposed addition, removal, or rearrangement. In cases of author addition or removal, confirmation from the respective author is also required. The Editor will only consider authorship changes after manuscript acceptance under extraordinary circumstances. During the Editor's review of the request, publication of the manuscript will be suspended. If the manuscript has already been published online, approved requests will result in a corrigendum.

6. Copyright and Licensing

For all articles published in The Indonesian Journal of Kidney and Hypertension, authors retain copyright. Articles are licensed under the Creative Commons Attribution 4.0 International License, enabling free access for readers. Furthermore, the article may be reused and quoted, provided that proper citation of the original published version is included. These terms facilitate broad utilization and dissemination of the work, while ensuring appropriate attribution to the authors.

Under exceptional circumstances, articles may be subject to different licensing terms. Should you possess specific conditions, such as those associated with funding requirements, preventing the application of the standard license, kindly notify the editorial office of the journal upon submission. Exceptions to the standard licensing terms will be considered by the publisher on a case-by-case basis.

7. Archiving and Repository

This journal employs the Lots of Copies Keep Stuff Safe (LOCKSS) system to establish a distributed archiving framework across participating libraries. It authorizes these libraries to establish enduring archives of the journal, facilitating preservation and restoration efforts.

8. Advertising

The Indonesian Journal of Kidney and Hypertension abstains from offering advertising space or accepting advertisements.

9. Marketing

The Indonesian Journal of Kidney and Hypertension utilizes focused and analytics-driven promotional initiatives to engage prospective authors. In executing these endeavors, the journal prioritizes the dissemination of accurate information while abstaining from practices, such as email spamming, that could negatively impact other parties.

In order to optimize the benefits for authors publishing in our journal, we aim to:

  • Enhance the design of the journal website for improved reader navigation.
  • Increase the discoverability of the journal on prominent search engines like Google.
  • Secure inclusion and comprehensive content coverage in international scientific databases.